SEC Form 4 · accession 0001209191-15-045302
Gevo, Inc. · GEVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ganesh Kishore
Director
Period of report
May 8, 2015
Accepted (ET)
May 21, 2015 · 3:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001392380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 8, 2015 | S | 24,692 | $5.44 | D | 111,429 | I | By Malaysian Life Sciences Capital Fund |
| Common StockF1,F2 | May 8, 2015 | S | 8,713 | $5.4987 | D | 102,716 | I | By Malaysian Life Sciences Capital Fund |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are held by Malaysian Life Sciences Capital Fund Ltd. ("Malaysian Life Sciences"). Ganesh Kishore, Ph.D. is the Chief Executive Officer of Malaysian Life Sciences and may be held to have voting and dispositive power over shares held by the fund. Dr. Kishore disclaims beneficial ownership of shares held by Malaysian Life Sciences except to the extent of his pecuniary interest therein.
- F2Additionally, the reporting person is the direct owner of 146,133 shares of common stock as previously reported on the Form 4 filed on July 1, 2014.